Abstract
We have determined the ability of the novel nonpeptide tachykinin (TK) NK3 receptor antagonist, SR 142801, [(S) -(N)-(1-(3-(1-benzoyl-3-(3,4-dichlorophenyl) piperidin-3-yl) propyl)-4-phenylpiperidin-4-yl)-N-methylacetamide] in inhibiting the nitric oxide (NO)-independent prejunctional inhibition of cholinergic twitches and the NO-dependent relaxation produced by the NK3 receptor selective agonist, senktide, in the circular muscle of the guinea-pig proximal colon. Under moderate load (10 mN) and isometric recording of mechanical activity, single pulse electrical field stimulation (EFS) produced atropine- and tetrodotoxin-sensitive twitch contractions of mucosa-free circular muscle strips from the guinea-pig proximal colon. In the presence of NK1 and NK2 receptor antagonists (SR 140333 0.01 μM and GR 94800 0.1 μM, respectively) the NK3 receptor selective agonist, senktide (EC50 33 pM) and the NK3 receptor preferring natural TK, neurokinin B (NKB, EC50 13 pM) produced a concentration-dependent slowly developing inhibition of cholinergic twitches. Senktide (1 nM) did not affect the contractile response to acetylcholine (1 gM) indicating that depression of evoked twitches occurs prejunctionally. The inhibitory effect of senktide was 'unaffected when evoked in the presence of the cyclooxygenase inhibitor (S)-ketoprofen (10 μM), guanethidine (10 μM), naloxone (0.3 μM), the GABAB receptor antagonist 2-hydroxysaclofen (10 μM) or the combined application of the adenosine A1 and A2 receptor antagonists, 8-cyclopentyl-1,3-dipropylxanthine (10 μM) and 3,7-dimethyl-l-propargylxanthine (30 μM) respectively.
In the presence of NK1 and NK2 receptor antagonists, the NO-synthase inhibitor l-nitroarginine (L-NOARG 30-100 μM) did not affect twitch inhibition induced by senktide (EC50 33 pM). The response to NKB (EC50 95 pM) was slightly reduced by L-NOARG, yet the bulk of the inhibitory effect of both agonists on cholinergic twitches was substantially independent of NO generation. SR 142801 (0.1–0.3 μM) produced a moderate rightward shift of the concentration-response curve to senktide without depression of the Emax to the agonist, yielding an apparent pKB value of 7.65.
Under low resting tone (3 mN) and isotonic recording of mechanical activity, mucosa-free circular muscle strips from the guinea-pig proximal colon gained a high intrinsic tone suitable for testing the response to relaxant agents. In the presence of atropine (1 μM), guanethidine (3 μM), SR 140333 (0.01 [M) and GR 94800 (0.1 μLM), senktide (EC50 50 pM) produced a concentration-dependent relaxation of the strips, which was blocked by L-NOARG. SR 142801 (0.01–0.1 μM) produced a large rightward shift of the L-NOARG-sensitive concentration-response curve to senktide yielding an apparent pKB value of 8.62. Under isometric recording condition, SR 142801 (0.1 μM) did not affect twitch inhibition produced by 3 nM clonidine. Under isotonic recording condition, SR 142801 did not affect the L-NOARG-sensitive relaxation produced by EFS.
The present results indicate that NK3 receptor stimulation produces a NO-dependent relaxation of the guinea-pig colon and a substantially NO-independent prejunctional inhibition of cholinergic twitches. The variable affinities of SR 142801 in antagonizing various senktide-induced neuromodulatory effects in the guinea-pig intestine suggest a possible intraspecies heterogeneity of NK3 receptors in the enteric nervous system.
Similar content being viewed by others
References
Drapeau G, D'Orleans-Juste P, Dion S, Rhaleb NE, Rouissi NE, Regoli D (1987) Selective agonists for substance P and neurokinin receptors. Neuropeptides 10:3–49
Emonds-Alt X, Doutremepuich JD, Heaulme M, Neliat G, Santucci V, Steinberg R, Vilain P, Bichon D, Ducoux JP, Proietto V, Van Broeck D, Soubrier P, Le Fur G, Breliere JC (1993) In vitro and in vivo biological activities of SR 140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol 250:403–413
Emonds-Alt X, Bichon D, Ducoux JP, Heaulme M, Miloux B, Poncelet M, Proietto V, Van Broeck D, Vilain P, Neliat G, Soubrier P, Le Fur G, Breliere JC (1995) SR 142801 the first potent nonpeptide antagonist of the tachykinin NK3 receptor. Life Sci Pharmacol Lett 56:P127-P132
Fox AJ, Morton IKM (1991) Mu and kappa opioid receptor modulation of 5-HT3 and NK-3 receptor-evoked release of acetylcholine from the guinea-pig ileum myenteric plexus. Naunyn-Schmiedeberg's Arch Pharmacol 344:8–15
Guard S, Watson SP (1987) Evidence for NK-3 receptor-mediated tachykinin release in the guinea-pig ileum. Eur J Pharmacol 144:409–412
Guard S, Watson SP, Maggio JE, Too HP, Watling KJ (1990) Pharmacological analysis of [3H]senktide binding to NK-3 tachykinin receptors in guinea-pig ileum longitudinal musclemyenteric plexus and cerebral cortex membranes. Br J Pharmacol 99:767–773
Hanani M, Chorev M, Gilon C, Selinger Z (1988) The actions of receptor-selective substance P analogs on myenteric neurons: an electrophysiological investigation. Fur J Pharmacol 153:247–253
Laufer R, Wormser U, Friedman ZY, Gilon C, Chorev M, Selinger Z (1986) Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin. Proc Natl Acad Sci USA 82:7444–7447
Laufer R, Gilon C, Chorev M, Selinger Z (1988) Desensitization with a selective agonist discriminates between multiple tachykinin receptors. J Pharmacol Exp Ther 245:639–643
Maggi CA, Giuliani S (1993) Multiple inhibitory mechanisms mediate NANC relaxation in the circular muscle of the guinea-pig colon. Naunyn-Schmiedeberg's Arch Pharmacol 347:630–634
Maggi CA, Patacchini R, Giachetti A, Meli A (1990) Tachykinin receptors in the circular muscle of the guinea-pig ileum. Br J Pharmacol 101:996–1000
Maggi CA, Patacchini R, Rovero P, Giachetti A (1993a) Tachykinin receptors and tachykinin receptor antagonists. J Anton Pharmacol 13:23–93
Maggi CA, Patacchini R, Meini S, Giuliani S (1993b) Nitric oxide is the mediator of tachykinin NK3 receptor-induced relaxation in the circular muscle of the guinea-pig ileum. Fur J Pharmacol 240:45–50
Maggi CA, Patacchini R, Meini S, Giuliani S (1994a) Effect of longitudinal muscle-myenteric plexus removal and indomethacin on the response to tachykinin NK2 and NK3 receptor agonists in the circular muscle of the guinea-pig ileum. J Anton Pharmacol 14:49–60
Maggi CA, Zagorodnyuk V, Giuliani S (1994b) Tachykinin NK3 receptor mediates NANC hyperpolarization and relaxation via NO release in the circular muscle of the guinea-pig colon. Regul Pept 53:259–274
Maggi CA, Patacchini R, Meini S, Quartara L, Sisto A, Potier E, Giuliani S, Giachetti A(1994c) Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. Br J Pharmacol 112:150–160
Mastrangelo D, Mathison R, Huggel HJ, Dion S, D'Orleans-Juste P, Rhaleb NE, Drapeau G, Rovero P, Regoli D (1986) The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. Fur J Pharmacol 134:321–326
Mc Elroy AB, Clegg SP, Deal MJ, Ewan GB, Hagan RM, Ireland SJ, Jordan CC, Porter B, Ross BC, Ward P, Whittington AR (1992) Highly potent and selective heptapeptide antagonists of the neurokinin NK2 receptor. J Med Chem 35:2582–2591
Patacchini R, Bartho L, Holzer P, Maggi CA (1995) Activity of SR 142801 at peripheral tachykinin receptors. Fur J Pharmacol 278:17–25
Tsuchida K, Shigemoto R, Yokota Y, Nakanishi S (1990) Tissue distribution and quantitation of the mRNA for three rat tachykinin receptors. Eur J Biochem 193:751–759
Wormser U, Laufer R, Hart Y, Chorev M, Gilon C, Selinger Z (1986) Highly selective agonists for substance P receptor subtypes. EMBO J 5:2805–2808
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giuliani, S., Maggi, C.A. Effect of SR 142801 on nitric oxide-dependent and independent responses to tachykinin NK3 receptor agonists in isolated guinea-pig colon. Naunyn-Schmiedeberg's Arch Pharmacol 352, 512–519 (1995). https://doi.org/10.1007/BF00169385
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169385